Bellevue Healthcare Share Discussion Threads

[semper vigilans] 28/8/2018 08:09

Would be good for all concerned if BBH invested in AGL & AOR if it hasn’t done so already.
Performance v. good anyway!

[jonwig] 11/5/2018 19:09

FT maybe explains recent strength:

Ater a brief wobble, drug stocks are moving broadly higher on Friday as US President Donald Trump unveiled plans to keep a lid on rising prices, primarily by targeting foreign countries he claims have been freeloading off American research and development.

Among the movers:

• The S&P 500 healthcare sector is now up 1.2 per cent after briefly dipping into negative territory at the start of the speech.

• Pharmacy chain CVS is up 1.7 per cent, and Walgreens is up 0.2 per cent.

• Healthcare services company Cardinal Health is up 1.17 per cent, McKesson is up 1.7 per cent, Express Scripts is up 2.86 per cent and AmerisourceBergen is up 1.87 per cent

• Drugmaker AbbVie is up 1.13 per cent, Pfizer is up 1.3 per cent, Merck is up 2.26 per cent, Bristol-Myers Squibb is up 1.17 per cent

• The Nasdaq biotechnology index is up 2.2 per cent, and biotech company Regeneron is up 7 per cent.

[jonwig] 09/4/2018 12:51

Factsheet out. Problems? Politics, mainly!

[jonwig] 04/4/2018 05:42

@ Toffee - dunno: March factsheet is due any day now. US markets aren't looking good.

[toffeeman] 03/4/2018 19:54

Now trading below Nav (for the first time I think).Someat oop?

[jonwig] 16/2/2018 06:54

Comment on BBH after the annual results:



Maybe answers your question, Toffeeman!

[toffeeman] 01/2/2018 16:23

Bit of a grim few days - is this pre-bear market?

[jonwig] 24/10/2017 05:24

BBH a part of this article:

[jonwig] 21/9/2017 06:10

Result of issue: 57,224,047 new shares at 112.1p.

[jonwig] 20/9/2017 10:37

We have an up-to-date NAV for last night: 110.48p, so issue price should be 112.14p.

[jonwig] 20/9/2017 09:00

Interview:

[jonwig] 19/9/2017 06:39

Latest NAV 111p so new shares would notionally be offered at ~112.7p. But if NAV fall is due to USD, it could continue and the offer overtaken by events. Can probably wait until noon tomorrow as unlikely to be over-subscribed, I think.

Issue price is determined as cum-inc NAV at today's close plus 1.5%. Unfortunately that won't be published until mid-afternoon tomorrow, so best estimate is yesterday's closing NAV to be published this afternoon.

[jonwig] 14/9/2017 17:49

A 1.5% mark-up on the latest NAV would put the offer price in the range 116.8 - 116.9p, which is just about what you can buy them for in the market. Anyone who wants a big chunk might take it up, but I'm unsure of the attraction.

[jonwig] 13/9/2017 19:09

Page 12: The price at which new Ordinary Shares will be issued pursuant to the
Second Issue will be calculated by reference to the prevailing NAV (cumincome)
of the existing Ordinary Shares together with a premium of
1.5 per cent. intended to cover the costs and expenses of the Second
Issue (including, without limitation, placing commissions). However, for
illustrative purposes only, assuming that 25,484,200 Ordinary Shares
are issued pursuant to the Second Issue and an issue price of 117.72
pence per new Ordinary Share ...

Page 14: Under the Intermediaries Offer, the Ordinary Shares are being offered to
Intermediaries in the United Kingdom, the Channel Islands and the Isle of
Man who will facilitate the participation of their retail investor clients
located in the United Kingdom, the Channel Islands and the Isle of Man.
A minimum subscription amount of £1,000 per Underlying Applicant will
apply. Completed Applications from Intermediaries must be received by
Peel Hunt no later than 3.00 p.m. on 20 September 2017.

[shauney2] 13/9/2017 15:08

Thanks for that jon.I could well have missed that.

[jonwig] 13/9/2017 14:58

Prospectus published. NAV above 115.2p now. Only until 20/09 to apply.

[jonwig] 08/9/2017 10:58

Citywire seems to know that they are planning a fundraising up to £200m at a premium to NAV. On current numbers, that suggests a price between 114.6p and 117p.I'd be quite keen to participate in that.

[jonwig] 23/6/2017 16:42

Shares issued at a premium.
Simple example:

1 share exists, assets 100, so nav 100.
Add 1 new share at price of 105.
So now 2 shares with assets 205, nav 102.5.
Underlying investments haven't moved.

That shows the arithmetic. Effect is smaller in real situations.

[toffeeman] 23/6/2017 16:14

Don't see how that follows - the nav depends on the performance of the investments - we should be indifferent to the number of shares in issue?

[jonwig] 23/6/2017 16:05

Toffee - we shareholders are getting a slice of that through nav increase.... I hope!

[toffeeman] 23/6/2017 15:29

So the company has raised a further 15% equity since the launch - all at a premium. Who takes the commission :)?

[jonwig] 10/6/2017 10:40

melody - thanks, I didn't know it had entered the SC index.
It's been pretty consistently at a premium, sometimes a much bigger one than now.
The managers have a strong track record.

[melody9999] 10/6/2017 09:04

this was drawn to my attention as I see it ie entering the ftse small cap. so some funds/trackers buying in? premium to NAV so probably the wrong time for an entry.

[toffeeman] 22/2/2017 15:56

It's a bit like the old privatisations without stagging!

12% return in just over 2 months is fine by me.

I took 12% out of WPCT when it launched - just wondering whether to do the same here....